Logo image of KRN.DE

KRONES AG (KRN.DE) Stock Fundamental Analysis

FRA:KRN - Deutsche Boerse Ag - DE0006335003 - Common Stock - Currency: EUR

129.4  -1.8 (-1.37%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to KRN. KRN was compared to 104 industry peers in the Machinery industry. While KRN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. KRN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

KRN had positive earnings in the past year.
In the past year KRN had a positive cash flow from operations.
KRN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years KRN had a positive operating cash flow.
KRN.DE Yearly Net Income VS EBIT VS OCF VS FCFKRN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

1.2 Ratios

The Return On Assets of KRN (5.50%) is better than 74.04% of its industry peers.
With a decent Return On Equity value of 13.59%, KRN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
KRN has a Return On Invested Capital of 11.32%. This is amongst the best in the industry. KRN outperforms 86.54% of its industry peers.
KRN had an Average Return On Invested Capital over the past 3 years of 9.15%. This is in line with the industry average of 8.43%.
The 3 year average ROIC (9.15%) for KRN is below the current ROIC(11.32%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 13.59%
ROIC 11.32%
ROA(3y)4.51%
ROA(5y)2.24%
ROE(3y)11.65%
ROE(5y)5.8%
ROIC(3y)9.15%
ROIC(5y)N/A
KRN.DE Yearly ROA, ROE, ROICKRN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

The Profit Margin of KRN (4.88%) is better than 60.58% of its industry peers.
In the last couple of years the Profit Margin of KRN has grown nicely.
KRN has a Operating Margin of 6.68%. This is comparable to the rest of the industry: KRN outperforms 56.73% of its industry peers.
KRN's Operating Margin has improved in the last couple of years.
KRN has a Gross Margin of 51.89%. This is in the better half of the industry: KRN outperforms 73.08% of its industry peers.
In the last couple of years the Gross Margin of KRN has remained more or less at the same level.
Industry RankSector Rank
OM 6.68%
PM (TTM) 4.88%
GM 51.89%
OM growth 3YN/A
OM growth 5Y2.88%
PM growth 3YN/A
PM growth 5Y3.94%
GM growth 3Y-0.5%
GM growth 5Y0.78%
KRN.DE Yearly Profit, Operating, Gross MarginsKRN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KRN is creating some value.
Compared to 1 year ago, KRN has about the same amount of shares outstanding.
Compared to 5 years ago, KRN has about the same amount of shares outstanding.
The debt/assets ratio for KRN is higher compared to a year ago.
KRN.DE Yearly Shares OutstandingKRN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
KRN.DE Yearly Total Debt VS Total AssetsKRN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

KRN has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
KRN has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. KRN outperforms 99.04% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that KRN is not too dependend on debt financing.
The Debt to Equity ratio of KRN (0.00) is better than 98.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACC1.62
WACC7%
KRN.DE Yearly LT Debt VS Equity VS FCFKRN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

KRN has a Current Ratio of 1.34. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.34, KRN is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
KRN has a Quick Ratio of 1.04. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of KRN (1.04) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.04
KRN.DE Yearly Current Assets VS Current LiabilitesKRN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

5

3. Growth

3.1 Past

KRN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.47%.
Measured over the past years, KRN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.22% on average per year.
KRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.86%.
The Revenue has been growing slightly by 4.14% on average over the past years.
EPS 1Y (TTM)6.47%
EPS 3YN/A
EPS 5Y8.22%
EPS Q2Q%20.93%
Revenue 1Y (TTM)9.86%
Revenue growth 3Y12.42%
Revenue growth 5Y4.14%
Sales Q2Q%13.22%

3.2 Future

KRN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.53% yearly.
The Revenue is expected to grow by 7.41% on average over the next years.
EPS Next Y23.68%
EPS Next 2Y20.42%
EPS Next 3Y18.07%
EPS Next 5Y14.53%
Revenue Next Year12.17%
Revenue Next 2Y10.07%
Revenue Next 3Y8.79%
Revenue Next 5Y7.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KRN.DE Yearly Revenue VS EstimatesKRN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KRN.DE Yearly EPS VS EstimatesKRN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

KRN is valuated correctly with a Price/Earnings ratio of 16.38.
62.50% of the companies in the same industry are more expensive than KRN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.80, KRN is valued a bit cheaper.
A Price/Forward Earnings ratio of 12.55 indicates a correct valuation of KRN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KRN indicates a somewhat cheap valuation: KRN is cheaper than 60.58% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.91, KRN is valued a bit cheaper.
Industry RankSector Rank
PE 16.38
Fwd PE 12.55
KRN.DE Price Earnings VS Forward Price EarningsKRN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as KRN.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KRN indicates a somewhat cheap valuation: KRN is cheaper than 66.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.89
EV/EBITDA 7.45
KRN.DE Per share dataKRN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

KRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KRN may justify a higher PE ratio.
A more expensive valuation may be justified as KRN's earnings are expected to grow with 18.07% in the coming years.
PEG (NY)0.69
PEG (5Y)1.99
EPS Next 2Y20.42%
EPS Next 3Y18.07%

4

5. Dividend

5.1 Amount

KRN has a Yearly Dividend Yield of 1.68%.
Compared to an average industry Dividend Yield of 3.03, KRN has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.39, KRN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

The dividend of KRN has a limited annual growth rate of 0.58%.
Dividend Growth(5Y)0.58%
Div Incr Years2
Div Non Decr Years3
KRN.DE Yearly Dividends per shareKRN.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

27.87% of the earnings are spent on dividend by KRN. This is a low number and sustainable payout ratio.
KRN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP27.87%
EPS Next 2Y20.42%
EPS Next 3Y18.07%
KRN.DE Yearly Income VS Free CF VS DividendKRN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M
KRN.DE Dividend Payout.KRN.DE Dividend Payout, showing the Payout Ratio.KRN.DE Dividend Payout.PayoutRetained Earnings

KRONES AG

FRA:KRN (3/28/2025, 2:21:05 PM)

129.4

-1.8 (-1.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-09 2025-05-09
Inst Owners22.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.09B
Analysts77.78
Price Target150.3 (16.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly Dividend1.75
Dividend Growth(5Y)0.58%
DP27.87%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.58%
Min EPS beat(2)-18.73%
Max EPS beat(2)53.89%
EPS beat(4)2
Avg EPS beat(4)6.46%
Min EPS beat(4)-18.73%
Max EPS beat(4)53.89%
EPS beat(8)5
Avg EPS beat(8)8.47%
EPS beat(12)9
Avg EPS beat(12)14.69%
EPS beat(16)12
Avg EPS beat(16)-8.67%
Revenue beat(2)2
Avg Revenue beat(2)0.87%
Min Revenue beat(2)0.08%
Max Revenue beat(2)1.67%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)1.67%
Revenue beat(8)4
Avg Revenue beat(8)0.24%
Revenue beat(12)7
Avg Revenue beat(12)0.81%
Revenue beat(16)9
Avg Revenue beat(16)0.6%
PT rev (1m)0.59%
PT rev (3m)0.63%
EPS NQ rev (1m)-2.95%
EPS NQ rev (3m)-6.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.14%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)0.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 16.38
Fwd PE 12.55
P/S 0.8
P/FCF 13.89
P/OCF 8.6
P/B 2.23
P/tB 3.23
EV/EBITDA 7.45
EPS(TTM)7.9
EY6.11%
EPS(NY)10.31
Fwd EY7.97%
FCF(TTM)9.32
FCFY7.2%
OCF(TTM)15.05
OCFY11.63%
SpS161.76
BVpS58.08
TBVpS40.11
PEG (NY)0.69
PEG (5Y)1.99
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 13.59%
ROCE 15.13%
ROIC 11.32%
ROICexc 13.09%
ROICexgc 18.47%
OM 6.68%
PM (TTM) 4.88%
GM 51.89%
FCFM 5.76%
ROA(3y)4.51%
ROA(5y)2.24%
ROE(3y)11.65%
ROE(5y)5.8%
ROIC(3y)9.15%
ROIC(5y)N/A
ROICexc(3y)12.41%
ROICexc(5y)N/A
ROICexgc(3y)16.71%
ROICexgc(5y)N/A
ROCE(3y)12.24%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y7.64%
ROICexc growth 3YN/A
ROICexc growth 5Y5.78%
OM growth 3YN/A
OM growth 5Y2.88%
PM growth 3YN/A
PM growth 5Y3.94%
GM growth 3Y-0.5%
GM growth 5Y0.78%
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 103.57%
Cap/Sales 3.55%
Interest Coverage 26.02
Cash Conversion 92.14%
Profit Quality 118.07%
Current Ratio 1.34
Quick Ratio 1.04
Altman-Z N/A
F-Score6
WACC7%
ROIC/WACC1.62
Cap/Depr(3y)84.83%
Cap/Depr(5y)80.1%
Cap/Sales(3y)3.05%
Cap/Sales(5y)3.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.47%
EPS 3YN/A
EPS 5Y8.22%
EPS Q2Q%20.93%
EPS Next Y23.68%
EPS Next 2Y20.42%
EPS Next 3Y18.07%
EPS Next 5Y14.53%
Revenue 1Y (TTM)9.86%
Revenue growth 3Y12.42%
Revenue growth 5Y4.14%
Sales Q2Q%13.22%
Revenue Next Year12.17%
Revenue Next 2Y10.07%
Revenue Next 3Y8.79%
Revenue Next 5Y7.41%
EBIT growth 1Y21.89%
EBIT growth 3YN/A
EBIT growth 5Y7.14%
EBIT Next Year80.14%
EBIT Next 3Y31.77%
EBIT Next 5Y19.84%
FCF growth 1Y11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.33%
OCF growth 3Y-24.66%
OCF growth 5Y-15.29%